UCLA research could lead to a simple saliva test capable of diagnosing — at an early stage — diabetes and cancer, and perhaps neurological disorders and autoimmune diseases.
The study, the most comprehensive analysis ever conducted of RNA molecules in human saliva, reveals that saliva contains many of the same disease-revealing molecules that are contained in blood. It was published online today by the peer-reviewed journal Clinical Chemistry and will be published in the journal’s January 2015 special print issue, “Molecular Diagnostics: A Revolution in Progress.”
“If we can define the boundaries of molecular targets in saliva, then we can ask what the constituents in saliva are that can mark someone who has pre-diabetes or the early stages of oral cancer or pancreatic cancer — and we can utilize this knowledge for personalized medicine,” said Dr. David Wong, a senior author of the research and UCLA’s Felix and Mildred Yip Endowed Professor in Dentistry.
Wong said the test also holds promise for diagnosing Type 2 diabetes, gastric cancer and other diseases. “If you don’t look in saliva, you may miss important indicators of disease,” Wong said. “There seems to be treasure in saliva, which will surprise people.”
RNA, widely known as a cellular messenger that makes proteins and carries out DNA’s instructions to other parts of the cell, is now understood to perform sophisticated chemical reactions and is believed to perform an extraordinary number of other functions, at least some of which are unknown.
Wong’s research over the past decade has focused on identifying biomarkers in saliva. His laboratory discovered that some of the same RNA that is inside human cells are also present in saliva and can be used to detect diseases — a surprising finding, he said, because enzymes in saliva can degrade RNA, making the mouth “a hostile environment.”
The new research is a collaboration with Xinshu (Grace) Xiao, the paper’s other senior author and a UCLA associate professor of integrative biology and physiology in the UCLA College. Using state-of-the-science genomics and bioinformatics, the researchers analyzed 165 million genetic sequences.
Among the many forms of RNA are some unusual ones that live in the mouth and in cells. For example, it wasn’t known until very recently that RNA comes in a circular form; the linear form has long been known. But the UCLA scientists identified more than 400 circular RNAs in human saliva — the first discovery of circular RNA in saliva or any body fluid — including 327 forms that were previously unknown.
Circular RNA’s function in saliva is not entirely understood, although it does serve as a sponge for tiny RNA molecules called microRNAs, which bind to it.
“Circular RNAs in saliva may be protecting other RNAs,” said Xiao, who also is a member of UCLA’s Molecular Biology Institute. It’s likely, she said, that circular RNAs in saliva protect microRNAs from being degraded.
MicroRNAs, which once seemed to be little more than molecular noise, play important roles in many cell types, and have been implicated in cancers and other diseases, Xiao said. One microRNA can regulate hundreds of genes, she said.
The scientists compared microRNA levels in saliva to those in the blood and other body fluids, and found the levels of microRNA in blood and in saliva are very similar — indicating that a saliva sample would be a good measure of microRNAs in the body.
They also found that saliva contains another class of small RNAs, called piwi-interacting RNAs, or piRNAs, which are produced by stem cells, skin cells and germ cells. There are very few piRNAs in blood and most other body fluids, but Xiao’s analysis showed that piRNA are abundant in saliva. Although their function is not yet known, Xiao said they may protect the body from viral infection.
While most RNA molecules translate genetic code from DNA to make proteins, there is also a class called non-coding RNAs that does not.
“Saliva carries with it non-coding RNAs, microRNAs, piRNAs and circRNAs that are biomarkers for disease and health monitoring,” said Wong, who also is associate dean of research at the UCLA School of Dentistry. “Had we not done this collaboration, we would never know that non-coding RNAs, microRNAs, piRNAs and circRNAs exist in saliva.”
Their overriding conclusion is that saliva has tremendous medical and scientific value. In the not-too-distant future, dentists might be able to take saliva samples to analyze for a variety of diseases. And, Wong says, the research could lead to a new category of self-diagnostic devices. “This could indicate that wearable gear that informs you whether you have a disease — even before you have any symptoms — is almost here,” he said.
The Latest on: Molecular diagnostics
[google_news title=”” keyword=”molecular diagnostics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Molecular diagnostics
- ESCMID Presenters Make Case for Saliva Samples in Molecular Infectious Disease Testingon April 30, 2024 at 11:06 am
As demonstrated during the COVID-19 pandemic and in newer research, saliva holds promise as an alternative sample type for PCR-based infectious disease testing.
- Hepatitis A Virus: Serology and Molecular Diagnosticson April 27, 2024 at 5:00 pm
Molecular diagnosis of HAV along with anti-HAV IgG avidity measurement are helpful in case of positive IgM where laboratory evidence of acute hepatitis is absent and there is no epidemiologic link ...
- Vietnam Molecular Diagnostic Market Upcoming Peaks Market Size’s Projection to Reach New Heightson April 24, 2024 at 2:16 pm
Report Ocean’s latest analysis delves into the “Vietnam Molecular Diagnostic Market” Report from 2024 to 2032, covering an array of market facets such as characteristics, size, growth, segmentation, ...
- Beyond Diagnostics: The expanding role of medical laboratories in West Africaon April 19, 2024 at 4:47 am
In 2023, on the World Health Organization’s 75th anniversary, a momentous timeline was unveiled. The timeline commemorated remarkable achievements and breakthroughs across the globe that have propelle ...
- Molecular Diagnostics Market to Reach USD 36.94 billion by 2031, North America to Hold 39% Shareon April 18, 2024 at 8:42 am
The Molecular Diagnostics market is experiencing a period of phenomenal growth, poised to be a major driver in the transformation of healthcare. This sector utilizes advanced techniques to analyse an ...
- Point-of-Care Molecular Diagnostics Market Estimated to Reach USD 11.3 Billion by 2033on April 15, 2024 at 5:00 pm
According to Market.us, the global market for Point-of-Care Molecular Diagnostics is projected to expand from USD 8.3 billion in 2023 to approximately USD 11.3 billion by 2033. This represents a ...
- Core Clinical Molecular Diagnostics Market to Reach $11.9 Billion, Globally, by 2032 at 9.5% CAGR: Allied Market Researchon April 15, 2024 at 7:40 am
Increase in demand for precision medicine, rise in the prevalence of chronic diseases, and advancements in molecular diagnostics technology drive the growth of the global core clinical molecular ...
- Bosch and Randox to expand molecular diagnostics in $159m partnershipon April 12, 2024 at 5:23 pm
Bosch Healthcare and diagnostic company Randox will invest $159m (€150m) to expand the former company’s Vivalytic analysis platform. The funds from the strategic partnership will see the two ...
- Male infertility genetic study improves molecular diagnostics and personalized management of patientson April 12, 2024 at 8:00 am
Half of these cases are due to male infertility—either caused by the complete absence or low number of mature sperm. In today's clinical practice, over half of these cases remain unexplained, ...
- Regulating Molecular Diagnostic Assayson April 8, 2024 at 5:00 pm
[12] A company intending to offer a molecular diagnostic assay for clinical application will be regulated as a device manufacturer. The FDA's regulatory requirements primarily fall into two major ...
via Bing News